Health Economist Shreds PBMs’ Claim of Large Cost Increase from “Any Willing Pharmacy” Medicare Proposal

Kevin Schweers
Published Online: Monday, July 28, 2014
Follow Pharmacy_Times:

Claims by pharmacy benefit managers (PBMs) that a massive cost increase would result from legislation giving Medicare seniors in medically underserved areas more convenient access to discounted or “preferred” copays are “theoretically baseless,” a noted health care economist and antitrust expert argues in a new analysis.

Dr. David M. Eisenstadt, veteran of the U.S. Department of Justice Antitrust Division and Principal at Microeconomic Consulting and Research Associates (MiCRA), was asked by the National Community Pharmacists Association (NCPA) to analyze a PBM cost estimate that The Ensuring Seniors Access to Local Pharmacies Act (H.R. 4577) would raise Medicare costs by $21 billion over 10 years. 

(H.R. 4577 is a proposal that would allow seniors to pay lower, “preferred” Medicare copays at any pharmacy willing to accept the insurance plan’s reimbursement and other contractual terms.)

According to Dr. Eisenstadt’s analysis:
  • It’s “not a foregone conclusion” that pharmacies that are offering discounted/”preferred” copays would raise their prices if more, competing pharmacies are allowed to provide the same discounts.
  • The PBMs’ methodology for alleging higher costs is “theoretically baseless” and “neither the actual nor intended formula used to calculate the price increase is supported by any theoretical rationale.”
  • The PBMs mischaracterize the findings of a prior analysis by the Centers for Medicare & Medicaid Services (CMS) of preferred and non-preferred drug costs by claiming that it demonstrates unambiguously that non-preferred pharmacies charge higher prices to the government than preferred pharmacies. In fact, CMS disproved that assumption and concluded that “when both mail and retail pharmacies are included, some sponsors’ preferred network pharmacies are offering somewhat higher negotiated prices than are offered by their non-preferred network pharmacies. Thus, our hypothesis that preferred network pharmacy negotiated prices are lower than non-preferred network pharmacy negotiated prices was not confirmed.”
  • Exclusive, “preferred pharmacy” arrangements could be propping up drug costs by limiting competition. “The theoretical economics literature on this type of ‘loyalty discount’ show that their effects are at best ambiguous, and if applied to this industry, a number of studies demonstrate that this form of ‘discounting’ could be used to both exclude other pharmacies from preferred networks and raise prices above levels that would prevail in the absence of such discounts.” [Note: In a footnote, Dr. Eisenstadt references several articles from economics literature; I linked the above text to just one as an example.]

The latest PBM claim follows a long line of “the-boy-who-cried-wolf” instances in which PBM claims of enormous cost increases do not hold up to scrutiny.
Related Articles
With prescription drug prices rising above reimbursement rates, many pharmacists are seeing patients struggle to access generic drugs.
The National Community Pharmacists Association today praised a Medicare final regulation to discourage Medicare Part D prescription drug plans from paying long-term care pharmacies lower, prorated dispensing fees for "short-cycle" prescriptions.
Seniors would have more convenient access to discounted or "preferred" copays for prescription drugs at their pharmacy of choice under new bipartisan legislation introduced recently and endorsed today by the National Community Pharmacists Association.
The Corrective Action Plan that federal Medicare officials have requested of Aetna is an important first step and the Centers for Medicare & Medicaid Services should go one further by issuing new guidance to all Medicare Part D prescription drug plan sponsors to prevent a 2016 repeat of the Aetna problems experienced in early 2015.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times